Alopecia Areata
📧 Sign up to get email alerts when something new happens for Alopecia Areata.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2025-05-26EMA Application withdrawn: Cinainu (dry aqueous extract of paullinia cupana seed;dry hydroethanolic extract of theobroma cacao seed;liquid ethanolic extract 30 per cent (W/W) of Allium cepa fresh bulb and Citrus limon fresh fruit) — Legacy Healthcare (France) S.A.S.
The European Medicines Agency has withdrawn the marketing authorization application for Cinainu for alopecia areata.
-
CLINICAL_TRIALS withdrawal · 2024-10-28Clinical Trial Update: Topical Crisaborole in Patients with Alopecia Areata [Phase 2]
A Phase 2 trial evaluating topical crisaborole for alopecia areata has been withdrawn from the study.
-
CLINICAL_TRIALS withdrawal · 2014-10-31Clinical Trial Update: Childhood Alopecia Areata Study Using the 308-nm Excimer Laser [NA]
The childhood alopecia areata trial investigating a 308-nm excimer laser has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-07-24Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata [Phase 2]
A Phase 2 clinical trial evaluating abatacept for moderate-to-severe alopecia areata has been withdrawn.